New facility expected to support expanded cGMP manufacturing of clinical and commercial supply of Company’s pipeline of mRNA cell therapies for the treatment of autoimmune diseases GAITHERSBURG, Md., ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback